NCT03359902View on ClinicalTrials.gov

Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

Transcutaneous vagal nerve stimulation

Non-invasive stimulation provided by transcutaneous electrical nerve stimulation device at 20Hz, 100 μs pulse width

DEVICE

Sham stimulation

Sham stimulation will be performed using electrodes placed on earlobe

Trial Locations (3)

32608

Malcom Randall VA Medical Center, Gainesville

McKnight Brain Institute, Gainesville

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Florida

OTHER

NCT03359902 - Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation | Biotech Hunter | Biotech Hunter